The Global Blood Crisis – Are We Solving the Wrong Problem?
Blood and plasma supply shortages remain a critical global health challenge, with significant implications for transfusion medicine, the availability of plasma-derived medicinal products, and equitable access to life-saving therapies.
Despite advances in donor recruitment and collection practices, ensuring a reliable and sustainable supply continues to require substantial investment in collection infrastructure, effective governance, long-term strategic planning, and coordination between blood services and plasma collection programmes.
These challenges are particularly pronounced in low- and middle-income countries, where limited collection capacity and unequal access to essential therapies further complicate efforts to meet patient needs. Addressing these systemic barriers is essential to strengthening global blood and plasma security and ensuring the sustainable availability of these vital medical resources.
In this episode of Hemostasis Today TV, hematology resident Maretta Aleksanyan speaks with David McIntosh, former Chief Executive of the Scottish National Blood Transfusion Service and an independent healthcare advocate, about the structural challenges behind persistent blood and plasma shortages and the need to rethink how countries secure these essential resources.
Drawing on his experience in blood services and healthcare advocacy, David McIntosh challenges the assumption that increasing donor numbers alone can resolve supply shortages.
He highlights the importance of investment in collection infrastructure, political commitment, and stronger coordination between blood services and plasma collection programmes.
The conversation explores how countries can build sustainable collection systems, whether regional cooperation could improve access to plasma-derived medicines, and how different approaches to donor recruitment and compensation influence supply strategies.
It also addresses the challenges facing low- and middle-income countries and the need for global health policies that prioritise equitable access to essential treatments.
At its core, the interview raises a fundamental question:
Are blood and plasma shortages primarily a problem of donor availability, or a failure to build systems capable of meeting patients’ needs?
Watch the full interview on Hemostasis Today TV.
Stay updated with Hemostasis Today TV.
-
Oct 20, 2026, 06:45Grant Garcia: Why Does a Blood Clot Diagnosis Immediately End an Athlete’s Season?
-
Oct 20, 2026, 06:35Parag Tamhankar: Landmark Study Reveals Genetic Spectrum and Targeted Therapies for ALPS in the Indian Population
-
Oct 20, 2026, 06:26Nina Houben: Neonatal Blood Transfusion Symposium and PhD Defense
-
Oct 20, 2026, 05:46Jan T. Kielstein: DNP Poisoning and Hemoadsorption The Limits of Rescue Therapy
-
Oct 20, 2026, 05:33Giulia Di Paolo: Connecting Plasma Donation to the Patients Who Depend on It
-
Oct 20, 2026, 05:20James Knowles: Exploring Plasma Manufacturing and Strengthening Industry Collaboration
-
Oct 20, 2026, 05:11Giuseppe Lippi։ Understanding Liver Test Abnormalities After AAV Gene Therapy
-
Oct 20, 2026, 05:02Sanam Loghavi: Test Your Hematology Knowledge at ASH 2026!
-
Oct 20, 2026, 04:13Ifeanyichukwu Ifechidere: DOACs Are Not the Answer to Every Anticoagulation Question